Dapasmart Trio Forte 1000 is a prescription medication used to manage type 2 diabetes in adults. It's a combination of three active ingredients: dapagliflozin, sitagliptin, and metformin, which work together to help control blood sugar levels.

Dapasmart M 10/1000 is a prescription medication used to manage type 2 diabetes. It combines two active ingredients: dapagliflozin (10mg) and metformin (1000mg). Dapagliflozin, an SGLT2 inhibitor, helps the kidneys remove excess sugar through urine, while metformin, a biguanide, reduces glucose production in the liver. This combination helps lower blood sugar levels in people with type 2 diabetes.

Dapagliflozin+Glimepiride+Metformin is used in the treatment of type 2 diabetes mellitus. Dapagliflozin + Glimepiride + Metformin is a combination of three antidiabetic medications. Dapagliflozin lowers blood sugar by causing the kidneys to get rid of more glucose in the urine.

Dapagliflozin+Glimepiride+Metformin is used in the treatment of type 2 diabetes mellitus. Dapagliflozin + Glimepiride + Metformin is a combination of three antidiabetic medications. Dapagliflozin lowers blood sugar by causing the kidneys to get rid of more glucose in the urine.

Dasanat 50 Tablet is used in the treatment of blood cancer (chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects.

DASakast 70mg Tablet is used in the treatment of blood cancer (chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects.

Dash 70mg Tablet is used in the treatment of blood cancer (chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects.

Dash 50mg Tablet is used in the treatment of blood cancer (chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects.

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells.[1] They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.[1][2] In these situations they decrease the need for blood transfusions.[2]